Luísa Soares* and Maria João Medeiros

Universidade da Madeira, Portugal

*Corresponding Author:Luísa Soares, Universidade da Madeira, Portugal.

Received: February 07, 2025; Published: February 13, 2025

Abstract

This study aimed to carry out a mini-review of literature about quality of life of patients diagnosed with ovarian cancer to understand the main influencing factors. It was possible to identify several relevant themes, such as resilience, social support, cognitive processing and the role of healthy coping strategies

Keywords: Cancer; Quality of Life; Psycho-oncology; Gynecological Cancer

References

1. WCRF International. Ovarian cancer statistics | World Cancer Research Fund International (2022).
2. Giornelli GH. “Management of relapsed ovarian cancer: a review”. SpringerPlus1 (2016): 1197.
3. Koster E B., et al. “Patient-centered outcomes on quality of life and anthroposophic healthcare: a qualitative triangulation study”. Quality of Life Research: An international Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation9 (2016): 2257-2267.
4. Groen R S., et al. “Updates and emerging therapies for rare epithelial ovarian cancers: one size no longer fits all”. Gynecologic Oncology2 (2015): 373-383.
5. Mangili G., et al. “Unraveling the two entities of endometrioid ovarian cancer: a single center clinical experience”. Gynecologic Oncology3 (2012): 403-407.
6. Oswald A J and Gourley C. “Low-grade epithelial ovarian cancer: several distinct clinical entities?” Current Opinion in Oncology5 (2015): 412-419.
7. Callegaro-Filho D., et al. “Small cell carcinoma of the ovary-hypercalcemic type (SCCOHT): A review of 47 cases”. Gynecologic Oncology1 (2016): 53-57.
8. Witkowski L., et al. “Clinical and genetic factors influence patient outcomes in small cell carcinoma of the ovary, hypercalcemic type”. Gynecologic Oncology3 (2016): 454-460.
9. Matulonis U A., et al. “Ovarian cancer”. Nature Reviews Disease Primers1 (2016).
10. Kindelberger D W., et al. “Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship”. The American Journal of Surgical Pathology2 (2007): 161-169.
11. Pentheroudakis G and Pavlidis N. “Serous papillary peritoneal carcinoma: unknown primary tumor, ovarian cancer counterpart or a distinct entity? A systematic review”. Critical Reviews in Oncology/Hematology 1 (2010): 27-42.
12. Jayson G C., et al. “Ovarian cancer”. The Lancet9951 (2014): 1376-1388.
13. Goff B A., et al. “Ovarian carcinoma diagnosis”. Cancer10 (2000): 2068-2075.
14. SEER Cancer Stat Facts. National Cancer Institute (2016).
15. Carvalho C and Soares L. ““REGULAR”: Psychological Intervention Program for Women Diagnosed with Thyroid Cancer”. ATSK Journal of Psychology1 (2025).
16. Alsop K., et al. “BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group”. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology21 (2012): 2654-2663.
17. Zhang S., et al. “Frequencies of BRCA1 and BRCA2 mutations among 1,342 unselected patients with invasive ovarian cancer”. Gynecologic Oncology 1212 (2011): 353-357.
18. Bassuk S S and Manson JE. “Oral contraceptives and menopausal hormone therapy: relative and attributable risks of cardiovascular disease, cancer, and other health outcomes”. Annals of Epidemiology3 (2015): 193-200.
19. Moorman P G., et al. “Oral contraceptives and risk of ovarian cancer and breast cancer among high-risk women: a systematic review and meta-analysis”. Journal of Clinical Oncology33 (2013): 4188-4198.
20. Soares L and Silva L. “Breast cancer: A review on quality of life, body image, and environmental sustainability”. World Journal of Cancer and Oncology Research 2 (2023): 133-144.
21. Soares L., et al. “Thyroid Cancer and Quality of Life: A Literature Review”. Clinical Journal of Obstetrics and Gynecology 7 (2024): 007-013.
22. Havrilesky L J., et al. “Oral contraceptive use for the primary prevention of ovarian cancer”. Evidence Report/Technology Assessment (212 (2013): 1-514.
23. Soares L and Dantas SA. “Cervical Cancer and Quality of Life: Systematic Review”. Clinical Journal of Obstetrics and Gynecology 7 (2024): 017-024.
24. Friebel TM., et al. “Modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: systematic review and meta-analysis”. Journal of the National Cancer Institute6 (2014): dju091.
25. Gaitskell K., et al. “Tubal ligation and ovarian cancer risk in a large cohort: Substantial variation by histological type”. International Journal of Cancer5 (2016): 1076-1084.
26. Rice MS., et al. “Tubal ligation, hysterectomy, unilateral oophorectomy, and risk of ovarian cancer in the Nurses' Health Studies”. Fertility and Sterility1 (2014): 192-198.e3.
27. Ahmed-Lecheheb D and Joly F. “Ovarian cancer survivors' quality of life: a systematic review”. Journal of Cancer Survivorship: Research and Practice5 (2016): 789-801.
28. Soares L., et al. “Oncological Disease in Metastatic Breast Neoplasia and Palliative Care: A review”. World Journal of Cancer and Oncology Research2 (2023): 122-132.
29. Santos P and Soares L. “Theoretical-practical Guidelines for Mental Health Professionals on Complicated Grief: a Systematic Review Based on Narrative Therapy”. Psychology and Behavioral Science International 1 (2024): 556080.
30. Zhang H., et al. “Resilience and Quality of Life: Exploring the Mediator Role of Social Support in Patients with Breast Cancer”. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research 23 (2017): 5969-5979.
31. Visser A., et al. “Spirituality and well-being in cancer patients: a review”. Psycho-oncology6 (2017): 565-572.
32. Tedeschi RG and Calhoun L G. “Posttraumatic growth: Conceptual foundations and empirical evidence”. Psychological Inquiry 15 (2004): 1-18.
33. Tedeschi R G and Calhoun L G. “The Posttraumatic Growth Inventory: Measuring the positive legacy of trauma”. Journal of Traumatic Stress 9 (1996): 455-471.
34. Schneider SM., et al. “Virtual Reality as a distraction intervention for women receiving chemotherapy”. Oncology Nursing Forum1 (2004): 81-88.
35. Soares L. “Psychology: The science of human behavior - A historical perspective”. Digital Journal3 (2023).
36. Santos Silva I., et al. “The role of technology in enhancing emotional wellbeing in recovery: Integrating WhatsApp for mutual support among care communities: A case of stroke survivors”. ATSK Journal of Psychology 2 (2024): 2709-5436.
37. Santos Silva I., et al. “Dimensions of Holistic Wellbeing (7DHW): A Theoretical Model”. Archives of Internal Medicine Research 7 (2024): 321-330.
38. Roland KB., et al. “A literature review of the social and psychological needs of ovarian cancer survivors”. Psycho-Oncology 22 (2013): 2408-2418.
39. Reis N., et al. “Quality of life and sexual functioning in gynecological cancer patients: results from quantitative and qualitative data”. European Journal of Oncology Nursing: The Official Journal of European Oncology Nursing Society2 (2010): 137-146.
40. Price M A., et al. “Prevalence and predictors of anxiety and depression in women with invasive ovarian cancer and their caregivers”. The Medical Journal of AustraliaS5 (2010): S52-S57.
41. Prati G and Pietrantoni L. “Optimism, social support, and coping strategies as factors contributing to posttraumatic growth: A meta-analysis”. Journal of Loss and Trauma 14 (2009): 364-388.
42. Peterman A H., et al. “Measuring spiritual well-being in people with cancer: the functional assessment of chronic illness therapy-Spiritual Well-being Scale (FACIT-Sp)”. Annals of Behavioral Medicine: a Publication of the Society of Behavioral Medicine1 (2002): 49-58.
43. Pensieri C and Pennacchini M. “Virtual Reality in Medicine”. In Handbook on 3D3C platforms (2016): 353-401.
44. Morris B A and Shakespeare-Finch J. “Rumination, posttraumatic growth, and distress: structural equation modeling with cancer survivors”. Psycho-Oncology 20 (2011): 1176-1183.
45. McDonough M H., et al. “Predicting changes in posttraumatic growth and subjective well-being among breast cancer survivors: the role of social support and stress”. Psycho-Oncology 23 (2014): 114-120.
46. Horesh D., et al. “Virtual Reality Combined with Artificial Intelligence (VR-AI) Reduces Hot Flashes and Improves Psychological Well-Being in Women with Breast and Ovarian Cancer: A Pilot Study”. Healthcare (Basel, Switzerland)11 (2022): 2261.
47. Hill EM and Watkins K. “Women with Ovarian Cancer: Examining the Role of Social Support and Rumination in Posttraumatic Growth, Psychological Distress, and Psychological Well-being”. Journal of Clinical Psychology in Medical Settings1 (2017): 47-58.
48. Gu Z H., et al. “A Study on the Psychological Factors Affecting the Quality of Life Among Ovarian Cancer Patients in China”. Cancer Management and Research 12 (2020): 905-912.
49. Green SM., et al. “Cognitive behavior therapy for menopausal symptoms (CBT-Meno)”. Menopause 9 (2019): 972-980.
50. Ferrell B., et al. “Psychological well-being and quality of life in ovarian cancer survivors”. Cancer 5 (2003a): 1061-1071.
51. Davis LZ., et al. “Changein spiritual well-being and psychological outcomes in ovarian cancer survivors.” Psycho-Oncology 27 (2018): 477-483.
52. Coburn SB., et al. “International patterns and trends in ovarian cancer incidence, overall and by histologic subtype”. International Journal of Cancer11 (2017): 2451-2460.
53. Canada A L., et al. “A 3-factor model for the FACIT-Sp”. Psycho-oncology 9 (2008): 908-916.
54. Cann A., et al. “Assessing posttraumatic cognitive processes: The event-related rumination inventory”. Anxiety, Stress, and Coping 24 (2011): 137-156.

Citation

Citation: Luísa Soares and Maria João Medeiros. “Quality of Life in Ovarian Cancer: Key Factors and Strategies to Overcome Challenges - A Mini-Review". Acta Scientific Women's Health 7.3 (2025): 16-22.

Copyright

Copyright: © 2025 Luísa Soares and Maria João Medeiros. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.